Intrathecal trastuzumab for leptomeningeal metastases

from Neuro-Oncology: The Podcast · host Drs. Iyad Alnahhas, Priya Kumthekar, Jeffrey Raizer

Dr. Iyad Alnahhas interviews Drs. Priya Kumthekar and Jeffrey Raizer about their recent manuscript entitled: A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2- positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics", published online in Neuro-Oncology in March 2023.

Episode metadata supplied by the publisher feed · Published Aug 11, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Intrathecal trastuzumab for leptomeningeal metastases

0:00 21:05

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 21 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on August 11, 2023.

Can I download this Neuro-Oncology: The Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!